Abstract:Abstract Introduction Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness, among other symptoms. This rare condition may be associated with negative impacts to patients’ lives, including impaired mental and physical health, increased stigma, and difficulty obtaining an education or maintaining employment. Previous studies that have identified the burden associated with narcolepsy have largely relied on quantitative methods (e.g., surveys), providing limited insights into the patient experience. This study used qualitative, in-depth interviews to characterize the burden of narcolepsy. Methods Participant recruitment included convenience and snowball sampling. Sixty-minute individual interviews were conducted online by trained qualitative researchers. Interviewers used a concept elicitation approach with a semi-structured interview guide to elicit descriptions of patients’ experiences. Interview transcripts were coded and thematically analyzed using inductive and deductive approaches. Results Twenty-two adults with narcolepsy (type 1 [NT1] =12; type 2 [NT2=10]) participated in this study (average age: NT1=35; NT2=44). Most identified as female (NT1=83%; NT2=70%) and white (NT1=75%; NT2=60%). Approximately half of participants were employed (NT1=58%; NT2=50%). Average time since diagnosis was 7 years for NT1 and 11 years for NT2. Participants described several ways that narcolepsy has negatively impacted their lives. All or nearly all participants cited impacts on: work and school activities (e.g., trouble concentrating on tasks, forgetting information, falling asleep during meetings or conversations; NT1=100%; NT2=100%), mental health (e.g., depression, frustration, anxiety, embarrassment, lack of motivation; NT1=100%; NT2=90%), and instrumental activities of daily living (e.g., home maintenance, cooking/preparing meals, driving; NT1=92%; NT2=100%). Most participants also described negative impacts on their relationships with family, friends, and romantic partners (e.g., reduced time spent with children, strain on marriage; NT1=83%; NT2=80%) and activities of daily living (e.g., eating, bathing, dressing/grooming, toileting; NT1=92%; NT2=60%). Conclusion Results from this study demonstrate the wide breadth of impacts narcolepsy has on patients’ lives and, in so doing, helps to fill a gap in the literature by providing rich insights into the patient experience of narcolepsy. Support (if any) This study was sponsored by Alkermes, Inc. and conducted in partnership with QualityMetric. The authors thank Megan Patsch for her contributions.

0602 Burden of Narcolepsy in Japan: A Nationwide Real-world Database Study from The Perspectives of Direct Medical Cost and Comorbidity

Burden of Narcolepsy in Japan: A Health Claims Database Study Evaluating Direct Medical Costs and Comorbidities

Epidemiology of narcolepsy and idiopathic hypersomnia in Japan: A retrospective analysis of health insurance claims from the Japan Medical Data Center

The economic consequences of narcolepsy

Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study

0673 The Burden of Living with Narcolepsy : Patient Perspectives from In-Depth Qualitative Interviews

Demographic characteristics and comorbidities of patients with narcolepsy: a propensity-matched cohort study

Epidemiology and real-world management of childhood epilepsy in Japan: A descriptive study using a health claim database

Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database

0667 Narcolepsy & Idiopathic Hypersomnia Patient Journey, Clinical Features and Treatments in a Real-World US Population

Correlation between prescription volumes of generic antiepileptic drugs and the number of clinical epileptologists across prefectural regions in Japan: A descriptive study using a national claims database

Trends and variation in issuance of high‐cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022

Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study

The socio-economical burden of hypersomnia

Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden

Medical cost for disability: a longitudinal observation of national health insurance beneficiaries in Japan

Incidence of pediatric narcolepsy diagnosis and management: evidence from claims data

Clinical Manifestations of Nonmotor Symptoms in 1021 Japanese Parkinson's Disease Patients from 35 Medical Centers

Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan

Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan